← back to search

Peter M. Siegel

McGill University Health Centre · CA
Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, HER2/EGFR in Cancer Research, Cancer Cells and Metastasis, and Cancer Mechanisms and Therapy.
h-index
65
citations
24,796
works
368
NIH funding
primary concept
email

Recent publications

The evolving landscape of brain metastasis: volume II
Trends in cancer 2025cited by 5position: middledoi
Single-cell spatial immune landscapes of primary and metastatic brain tumours
Nature 2023cited by 379position: middledoi
Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights
British Journal of Cancer 2022cited by 83position: middledoi
Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer
Cell Metabolism 2021cited by 141position: middledoi
Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver Metastasis
Cell Reports 2019cited by 247position: lastdoi
Dipeptidase-1 Is an Adhesion Receptor for Neutrophil Recruitment in Lungs and Liver
Cell 2019cited by 143position: middledoi
Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides
Cell Metabolism 2018cited by 87position: middledoi
EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours
Oncogene 2018cited by 42position: middledoi
The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L
eLife 2016cited by 35position: middledoi
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Cell Metabolism 2015cited by 556position: lastdoi
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Nature Genetics 2014cited by 464position: middledoi
Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer
Journal of Clinical Oncology 2014cited by 107position: middledoi
Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR
Nature Genetics 2013cited by 201position: middledoi
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Nature 2012cited by 2,671position: middledoi
Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
Acta Neuropathologica 2012cited by 421position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sébastien Tabariès · McGill University Health Centre4 papers (2015–2019)Matthew G. Annis · McGill University Health Centre3 papers (2015–2021)Zhifeng Dong · McGill University Health Centre2 papers (2012–2015)Russell G. Jones · Van Andel Institute2 papers (2015–2019)Sylvia Andrzejewski · McGill University Health Centre2 papers (2015–2019)Gelareh Zadeh · Mayo Clinic2 papers (2012–2025)Franco J. Vizeacoumar · University of Saskatchewan1 papers (2018–2018)Olivia A. Maguire · Columbia University1 papers (2021–2021)Varun Venkataramani · DKFZ-ZMBH Alliance1 papers (2025–2025)Mansoor N. Saleh · Aga Khan University Hospital Nairobi1 papers (2014–2014)Sarah E. Ackerman · Rockefeller University1 papers (2021–2021)Djihad Hadjadj · McGill University Health Centre1 papers (2012–2012)Xiaoguang Hao · University of Calgary1 papers (2019–2019)Xiaoyang Liu · Dalhousie University1 papers (2012–2012)Tae‐Hyung Kim · SK Group (South Korea)1 papers (2018–2018)David Jones · Mayo Clinic in Florida1 papers (2012–2012)Jennifer Green · Duke University1 papers (2014–2014)Brian E. Hsu · McGill University Health Centre1 papers (2019–2019)Steffen Albrecht · McGill University Health Centre1 papers (2012–2012)Michael R. Green · The University of Texas MD Anderson Cancer Center1 papers (2016–2016)